Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
about
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic reviewAntibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?Pneumococcal carriage and antibiotic susceptibility patterns from two cross-sectional colonization surveys among children aged <5 years prior to the introduction of 10-valent pneumococcal conjugate vaccine - Kenya, 2009-2010Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in MalawiEffect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western KenyaCotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority TrialRisk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy.High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya.Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in KenyaThe burden of common infectious disease syndromes at the clinic and household level from population-based surveillance in rural and urban KenyaAnti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations.Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable elementA randomized trial of prolonged co-trimoxazole in HIV-infected children in AfricaDoes trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review.Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP.High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introductionThe prevalence of malaria in people living with HIV in Yaounde, Cameroon.Mortality trends from 2003 to 2009 among adolescents and young adults in rural Western Kenya using a health and demographic surveillance systemImpact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.Carriage rate and serotypes of Streptococcus pneumoniae amongst children in Thika Hospital, Kenya.Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.Multi-drug resistant non-typhoidal Salmonella associated with invasive disease in western Kenya.A brief review on features of falciparum malaria during pregnancy.
P2860
Q21133667-B025E51D-9FAF-4314-B082-E8E7AE4DB435Q28076750-789FF763-5DEF-4053-A789-982C8F4309E3Q28359834-44E693A2-AB41-49C6-B080-E3C53CAD1EBFQ28387497-1AAF3B65-3AFE-40DA-B1DA-544336897F25Q28477925-FC9840A7-25F6-497D-B7E4-BACE8FC1C8E0Q28552031-7808C46C-0B2F-404C-99A2-817313A799E3Q33584240-92F3615A-EC44-41A0-8924-B0B11518C863Q33614281-E3DB3BCE-DC12-4897-A8EC-89BADA9D3FDAQ33757902-1C263FCF-A5EC-4D81-BB59-8C0371FD75D5Q33803895-D62D25EE-CC7F-4F4A-AD48-8288DBD52AA3Q34134036-2F46D4D4-6FE7-4809-B26B-F0052D6B2AA8Q34292830-38BBE427-D03E-4210-B5AE-0A4D7AC54CCBQ34687538-56F38DB1-1757-4358-A329-5082DF01B047Q34762420-F03FD350-BF13-4259-B925-067691217AACQ35725154-9BAC4B24-9BD1-4544-A164-3295FC5EFE6EQ35896017-884658FF-07ED-464E-8815-EB8766E936D4Q36130329-E4657AEC-0082-4E50-83EC-0D6FDA755ECAQ36373634-A140E521-32DB-4707-B0B1-9A443D8C6298Q36759511-0CC20072-13D3-4FFB-89B3-356606739F9AQ37350124-1286A9C2-3B40-4832-861F-83F25A5DAB1CQ40375985-5CB0BAA2-905C-4F89-A2CE-6788F5C6A96BQ43756016-DEEAFFC0-C1CF-4AD1-B382-8E188341B57AQ46265061-19DE85E1-18CE-415B-9D49-3A262DFE4139Q48252926-6734E007-B0E1-4FD1-B354-422577FB2D2DQ49874138-17501F97-B443-47C0-B9DA-7814A6E048F4
P2860
Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@en
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@nl
type
label
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@en
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@nl
prefLabel
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@en
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@nl
P2093
P50
P1476
Does cotrimoxazole prophylaxis ...... nt pathogens in Kenyan adults?
@en
P2093
Amanda Poe
Barbara Marston
Benjamin Ochieng
Carolyn Greene
Christina Polyak
Daniel R Feikin
Eric Mintz
John T Brooks
John Williamson
Kephas Otieno
P304
P356
10.4269/AJTMH.2008.79.320
P407
P577
2008-09-01T00:00:00Z